Bayer stock seen as potential buying opportunity

Bayer, a German pharmaceutical and life science company, faces significant challenges. The company has struggled with ongoing litigation, rising debt, and declining profits in recent years. Despite these issues, some analysts believe Bayer may still be a good investment. They argue that the company’s long-term potential might outweigh current problems. Investors are closely watching Bayer's performance, hoping for a turnaround. The company’s stock has not performed well in the past, causing concerns among investors. However, some experts suggest that Bayer's position in the market and ongoing efforts might lead to recovery.